Figure S2 from Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma

Authors :: Thomas Decaens
Vincent Leroy
Patrice N. Marche
Benoit Busser
Yi Yu
Giovanni Abbadessa
Séyédéh Tayébéh Ahmad Pour
Keerthi Kurma
Ayca Zeybek Kuyucu
Zuzana Macek Jilkova
Gaël S. Roth
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Migration

Full Text Access

Tools